Financial News
Latest News about PFE
Recent news which mentions PFE
Sorrento's COVID-19 Main Protease Inhibitor Neutralizes Omicron
January 28, 2022
From Benzinga
From Motley Fool
From Motley Fool
Is Pfizer About to Have Another Megablockbuster Drug in Its Lineup?
January 28, 2022
Tickers
PFE
From Motley Fool
From Motley Fool
10 Best Stocks to Buy for Your Income-Generating Portfolio
January 28, 2022
From InvestorPlace
From Motley Fool
Why Novavax Stock Is Sinking Again This Week
January 27, 2022
From Motley Fool
Why Opko Health Stock Is Crashing This Week
January 27, 2022
From Motley Fool
Say Hello to 2022’s Dogs of the Dow: 10 Dividend Stocks to Watch
January 27, 2022
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2022
From Benzinga
CHMP Recommends Pfizer's Paxlovid For Use In Adults With COVID-19
January 27, 2022
Tickers
PFE
From Benzinga
U.S. daily COVID case tally now falling and hospitalizations seem to be peaking, as Moderna launches trial of omicron-specific booster
January 27, 2022
From MarketWatch
From MarketWatch
Hoth's Management Team And Scientific Advisory Board Report Wrapping Up A Busy 2021 Of Clinical Research
January 27, 2022
From Benzinga
1 Top Biotech Stock Ready for a Bull Run
January 27, 2022
From Motley Fool
From Benzinga
Could Vaxart's Vaccine Pill Help to End the Pandemic?
January 27, 2022
From Motley Fool
Why Coronavirus Vaccine Stocks Topped the Market Today
January 26, 2022
From Motley Fool
2 Stocks to Buy No Matter What Happens in 2022
January 26, 2022
From Motley Fool
From InvestorPlace
From InvestorPlace
Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments
January 25, 2022
From MarketWatch
Cannabis Movers & Shakers: Flora Growth, The Green Organic Dutchman, Trade Roots And TrueGreen
January 25, 2022
From Benzinga
Pfizer, BioNTech Launch Omicron-Targeted COVID-19 Vaccine Trial
January 25, 2022
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data
January 25, 2022
From Benzinga
Here's What to Look For in Pfizer's Upcoming Earnings Report
January 25, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.